Compare alternative providers
Alternatives to The Edit
The Edit grades C (70.4/100), #118 of 542 on our scorecard. Start with a featured alternative, then explore providers with similar listed prices and treatment options. Compare their scores and terms below.
You're comparing against
The Edit →Featured alternative
CoreAge Rx scores 89.5/100. Check the price conditions and care terms against The Edit.
CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
More options to compare
High-disclosure, high-oversight compounded program with the cleanest verification signals.
FDAWarning letter issued to Eden Health International Inc. dba Eden in June 2026. See the FDA warning-letter database.
WeightRx is a telehealth provider publishing compounded semaglutide at $250/mo and compounded tirzepatide at $83/mo.
Telehealth wellness clinic offering GLP-1 medications on a 4-week billing cycle.
A men's-only compounded GLP-1 program that names its pharmacy (Strive Pharmacy, 503A since 2018) and its Chief Medical Advisor — real transparency signals most compounders skip.
AHBARx prices semaglutide and tirzepatide openly before any intake, names its founder as a physician, and leaves its own legal pages half-written.
The 6 alternatives above offer other options to compare with The Edit. Every provider we grade — all 542 of them — is scored on the same six factors: browse every graded provider.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.